Periodontitis and Systemic Diseases

155.Sabio G, Davis RJ. CJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance. Trends Biochem Sci 2010;35:490–496.

156.Tunes RS, Foss-Freitas MC, Da Rocha Nogueira-Filho G. Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc 2010;76:a35.

157.Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F, Seufert J. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells. Diabetes 2005;54:3410–3417.

158.Brown JEP, Thomas S Digby JE, Dunmore SJ. Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett 2002;513: 189–192.

159.Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol 2001;72:1254–1257.

160.Karthikeyan BV, Pradeep AR. Gingival crevicular fluid and serum leptin: Their relationship to periodontal health and disease. J Clin Periodontol 2007;34:467–472.

161.Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 2010;81:1118–1123.

162.Zimmermann GS, Bastos MF, Dias Gonçalves TE, Chambrone L, Duarte PM. Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol 2013;84: 624–633.

163.Pajvani UB, Du X, Combs TP, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications for metabolic regulation and bioactivity. J Biol Chem 2003;278:9073–9085.

164.Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473–2476.

165.Dunmore SJ, Brown JEP. The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol 2013;216:T37–T45.

166.Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2014;16:378–400.

167.Nokhbehsaim M, Eick S, Nogueira AV, et al. Stimulation of MMP-1 and CCL2 by NAMPT in PDL cells. Mediators Inflamm 2013;2013:437123.

168.Tüter G, Kurtiş B, Serdar M, et al. Effects of phase I peri­odontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1. J Clin Periodontol 2005;32:1011–1015.

169.Arakaki PA, Marques MR, Santos MCLG. MMP-1 polymorphism and its relationship to pathological processes. J Biosci 2009;34:313–320.

170.Zhao J. Interplay among nitric oxide and reactive oxygen species: a complex network determining cell survival or death. Plant Signal Behav 2007;2:544–547.

171.Griendling KK, Touyz RM, Zweier JL. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association. Circulation Res 2016;119:e39–e75.

172.Filippo C, Verza M, Coppola L, Rossi F, D’Amico M, Marfella R. Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree. Curr Diabetes Rev 2007;3:268–273.

173.D’Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe peri­odontitis. J Dent Res 2010;89:1241–1246.

174.Herrera BS, Martins-Porto R, Campi P, et al. Local and cardiorenal effects of periodontitis in nitric oxide-deficient hypertensive rats. Arch Oral Biol 2011;56:41–47.

175.Herrera BS, Martins-Porto R, Maia-Dantas A, et al. INOS-­derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats. J Periodontol 2011;82:1608–1615.

176.Lavrovsky Y, Chatterjee B, Clark RA, Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000;35: 521–532.

177.Allen EM, Matthews JB, O’Halloran DJ, Griffiths HR, Chapple IL. Oxidative and inflammatory status in type 2 diabetes patients with periodontitis. J Clin Periodontol 2011;38:894–901.

178.Roberts HM, Grant MM, Hubber N, Super P, Singhal R, Chapple ILC. Impact of bariatric surgical intervention on peripheral blood neutrophil (PBN) function in obesity. Obes Surg 2018;28:1611–1621.

179.Atabay VE, Lutfioğlu M, Avci B, Sakallioglu EE, Aydoğdu A. Obesity and oxidative stress in patients with different periodontal status: a case-control study. J Periodontal Res 2017;52:51–60.

180.Pacher P, Beckman J, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424.

181.Campi P, Herrera BS, de Jesus FN, et al. Endothelial dysfunction in rats with ligature-induced periodontitis: participation of nitric oxide and cycloxygenase-2-derived products. Arch Oral Biol 2016;63:66–74.

182.Assmann TS, Brondani LA, Bouças AP, et al. Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis. Nitric Oxide 2016;61:1–9.

183.Daffu G, del Pozo CH, O’Shea KM, Ananthakrishnan R, Ramasamy R, Schmidt AM. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci 20131;14:19891–19910.

184.Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients 2010;2:1247–1265

185.Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 2011; 1243:88–102.

186.Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 1990;87: 9010–9014.

187.Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003;108:1070–1017.

188.Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(ε)- (carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457–468.

189.Schmidt AM, Yan S Du, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a ­mechanism for chronic vascular dysfunction in diabetic ­vasculopathy and atherosclerosis. Circ Res 1999;84:489–497.

190.Chang PC, Chien LY, Yeo JF, et al. Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes. J Periodontol 2013;84:379–388.

191.Lin SJ, Tu YK, Tsai SC, Lai SM, Lu HK. Non-surgical peri­odontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial. Clin Oral Investig 2012;16:599–609.

192.Goova MT, Li J, Kislinger T, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001;159:513–525.

193.Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004;63:582–592.

194.Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889–9897.

194a.Akram Z, Alqahtani F, Alqahtani M, Al-Kheraif AA, Javed F. Levels of advanced glycation end products in gingival crevicular fluid of chronic periodontitis patients with and without type-2 diabetes mellitus. J Periodontol 2020;91:396–402.